Philadelphia Marriott Downtown, Philadelphia, PA. View Online Program! Brooklyn Heights is a neighborhood with more than 500 Antebellum homes and buildings. Founder & CSO, GenomeFrontier Therapeutics, Inc. For sponsorship and exhibition opportunities, please contact: Biogate Scientific Center brings to you the 3rd edition Vaccines Summit Boston 2023 scheduled for May 22-24, 2023. Take the survey now. What do they have in common, and what makes them different? Boston The American Society of Gene & Cell Therapy (ASGCT) is the primary membership organization for scientists, physicians, professionals, and patient advocates involved in gene and cell therapy. The 2020 Wayne County High School graduate and four-year letterman in soccer had plans to pursue a criminal justice degree. You also receive our free newsletter. You can also make a donation by PayPal and support the Gene Therapy Net website. A full-service partner for plasmid DNA, viral . Molecular Therapy is the leading journal for gene and cell therapy research, publishing important peer-reviewed research and cutting-edge reviews and commentaries. You also receive our free newsletter. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Hanson WadeProducts Gene Therapy Gene therapies are redefining the treatment of a host of devastating diseases, giving hope to patients who previously had no therapeutic options. Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. JesupSamuel "Dylan" Hargrove, 21, of Jesup died on Jan. 1, 2023 from injuries sustained from an automobile accident. NOW OPEN: Register for the 26th Annual Meeting! Waukesha, WI 53186. Tracks and Themes TRACK 1: Advances in Therapeutic Development Across Modalities Track Theme: Recent advances in therapeutic development across modalities, including gene therapy, . Click here to suggest. Associate Professor, Department of Microbiology and Immunology / Scientific Co-founder, University of California, San Francisco (UCSF) / Arsenal Bio, Garry Menzel, PhD, MBA . Will development in China continue and if so, how do we harmonize that with what we need to be able to develop CAR-Ts in the US and EU? As per available reports about 10 relevant journals, 15 Conferences, 30 workshops are presently dedicated exclusively to breathing disorderand about 2,070articles are being published on Gene Therapy. Managing Director, Next Pillar Consulting, Roundtable #3: Cell Therapy Combinations: Key Questions, Challenges and Progress. Recent Advances in Gene Therapy Technologies scheduled on January 14-15, 2025 in January 2025 in Zurich is for the researchers, scientists, scholars, engineers, academic, scientific and university practitioners to present research activities that might want to attend events, meetings, seminars, congresses, workshops, summit, and symposiums. President, CTO & Co-founder, CTRL Therapeutics, Jan ter Meulen, MD, PhD It brings together leading biotech and pharma industry experts, academicians, and decision makers who are passionate about addressing major global issues by turning ideas into solutions. Have a question? If you would like to register a team of 3 or more, please contact. The rooms would be allocted on a 'first come first serve" basis based on the registration date. The 2023 Advancing Gene Therapy conference will be held in The Westin Walthum, MA. Follow gene therapy from the laboratory to a patient. Join our mailing list to receive exclusive content and offers. Registration is free and allows users complete access to all sections of the site, including archived news items. Hanson Wade's goal is to accelerate progress within organisations and across industries. . Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Submit an Abstract. VP, Development Program Lead, Cell Therapy Development, BMS, Kanya Rajangam, MD, PhD Advanced Therapies Week is the destination for developers, investors and solution providers whose goal is to bring cell and gene therapies to patients. Through a comprehensive program filled with keynote plenaries, interactive group sessions, and focused discussion days, all carefully co-curated with industry leading figures, no matter which challenges your team are currently grappling with, weve got you covered. 2022 has been a landmark year for the global gene therapy space. Kentico CMS Development by Reason One | Powered by Kentico. Pre-Filled Syringes and Injectable Drug Devices Europe, Cell & Gene Therapy Conferences at PepTalk 2023, Transdermal and Microneedle Drug Delivery, Next Generation Ophthalmic Drug Delivery Summit, 2nd Annual mRNA-Based Therapeutics Summit, 2nd Allogeneic Cell Therapies Summit Europe, 3rd TGF- for Immuno-Oncology Drug Development Summit, 6th Annual Cell & Gene Therapy Innovation Summit, Retinal Vascular Disease Drug Development Summit, 11th Alzheimers & Parkinsons (Gene Therapy) Drug Development Summit, 3rd Annual Gene Therapy for Muscular Disorders Summit, GENAP Summit 2023 - Gene & Cell Therapy Aseptic Processing Technology, 6th Antigen-Specific Immune Tolerance Summit, Cell & Gene Therapy Research & Development Congress Asia, 4th Supply Chain and Logistics for Cell Therapies Summit, 12th Spring Meeting of the International Society for BioProcess Technology, 6th Annual Gene Therapy for Rare Disorders 2023 Summit, Reuters Pharma USA 2023 - Cell and Gene Therapies, International Bioprocessing and Biologics 2023 - Cell and Gene Therapies, 2nd LNP Formulation & Process Development Summit 2023 - Gene Therapy delivery, mRNA Process Development & Manufacturing Summit Europe, The Economist's Cell & Gene Therapy summit, 4th Gene Therapy Analytical Development Europe Summit, ISBioTech Nucleic Acids meeting - Production of DNA and RNA Biotherapeutics, 2nd Next Generation RNA Therapeutics Summit, American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Global Biologics Cell and Gene Legal Summit, Annual meeting of the Netherlands Society of Gene & Cell Therapy, Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting, 31th Annual Meeting of the European Society of Gene & Cell Therapy (ESGCT), Your conference not listed? We use cookies to ensure that we give you the best experience on our website. Tel: +1-512-474-7278 Overseas, July and August brought EMA approvals for PTC Therapeutics'Upstaza and BioMarins Roctavian, the first gene therapies for AADC deficiency and Haemophilia A respectively. Consulting Regulatory Scientist Advbiols Markus Haindl Global Head Gene Therapy Technical Operations Roche Far from the typical meet-and-greet exhibition experience, you as a sponsor or exhibitor will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list. OriGen Biomedical has many global distributors. Lead Partner. Customer Product Survey with more than 20 presentations across two days, the cell & gene therapy research & development congress asia will provide a platform for leading biopharma and biotech leaders, academicians and researchers to discuss topics on emerging advances in the field of cell and gene therapy, the regenerative potential of stem cells, application of t- Click here to suggest. Phil Tai, PhD, shareshis top 10 tips. Copyright 2023 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Chief Scientific Officer and Co-Founder, Lupagen, Andrew Scharenberg, MD Our mission is to advance knowledge, awareness, and education leading to discovery and clinical application of gene and cell therapies to alleviate diseasewe do that by serving as a catalyst to transform medicine by advancing gene and cell therapies to benefit patients and society. TRACK A: NOVEL ENGINEERED CELL THERAPIES AND CONCEPTS, Anish Suri, PhD Cell and Gene Therapy ICCGT 2023: 17. International Conference on Cell and Gene Therapy March 27-28, 2023 in Singapore, Singapore DIGITAL Conference Code: 23SGSI03ICCGT001 Submit Your Paper Author Registration Listener Registration About Venue Call For Papers Important Dates Committees Registration Fees Program Conference Photos Flyer Gene therapy, cell therapy and gene editing are fields of biomedical research with a similar goal in mind: To treat disease by changing our genetic makeup. Director, President, CEO & Co-founder, In8bio. A common bottleneck during regulatory interactions is in the manufacturing side of gene therapy programs. VP and Head, Cellular Therapy Clinical Development, BMS, Roundtable #4: CAR-T Development in China: What we Need to Know, Regulatory Considerations and Impact on the Field. CSO, Turnstone Biologics. Whats Unique to Cell Therapy Clinical Development That Can Help Solve Challenges the Industry May Face? Gene Therapy for Rare Disorders: Searchlight is a vital year-round knowledge sharing and problem solving network designed to accelerate the safe delivery of gene therapies to rare disorder patients. Precision ADVANCE, a collection of interconnected services and complementary teams across Precision for Medicine, Project Farma, and Precision Value & Health are uniquely focused on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully . Learn About the Annual Meeting Registration Abstracts Program Hotel & Travel Sponsor & Exhibit About 10 Tips to Submit Your Abstract Wondering how to craft a great Annual Meeting abstract submission? Contact Us It has set the aims, policies, solutions, and consensus path forward for the sector over each successive 12 months, addressing the biggest bottlenecks in cell and gene therapy development. (Andrii Yalanskyi/Shutterstock) PitchBook analyst Aaron Degagne reports from JP Morgan's healthcare conference in San Francisco with some gene therapy news: Startup ReCode Therapeutics has struck new partnerships with Bayer's AskBio and the Cystic Fibrosis Foundation. We value your ROI and will work with you directly on your specific goals and targets thats why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated. Chief Program Officer, Alliance for Cancer Gene Therapy, Shana Kelley, PhD President & CEO, Notch Therapeutics, Bob Valamehr, PhD, MBA International Conference on Animal Biotechnology and Genetherapy (ICABG), International Conference on Genome Editing, Modification and Gene Therapy (ICGEMGT), International Conference on Molecular Biotechnology and Gene Therapy (ICMBGT), International Conference on Advanced Gene Therapy Technologies (ICAGTT), International Conference on Advances in Gene Therapy Technologies (ICAGTT), International Conference on Gene and Cell Therapy (ICGCT), International Conference on Human Genetics and Genetic Disorders, Global Conference on Traditional and Alternative Medicine, International Conference on Gene Therapy Technology (ICGTT), International Conference on Gene Therapy Research and Technologies (ICGTRT), International Conference on Gene Therapy and Genetic Vaccines (ICGTGV), International Conference on Gene Therapy (ICGT), International Conference on Gene Therapy Technologies and Applications (ICGTTA), International Conference on Genes and Gene Therapy (ICGGT), International Conference on DNA Vaccination and Gene Therapy (ICDNAVGT), International Conference on Human Gene Therapy (ICHGT), Annual Congress on Genetic Engineering and Human Genetic Disorder, International Conference on Cell and Gene Therapy (ICCGT), International Conference on Red Biotechnology and Gene Therapy (ICRBGT), International Conference on Gene Therapy for Cancer (ICGTC), International Conference on Cellular Therapy and Regenerative Medicine (ICCTRM), International Conference on Viral Vectors, Gene Therapy and Vaccine (ICVVGTV), International Conference on Medical Biotechnology and Gene Therapy (ICMBGT), International Congress of Cancer Genomics, International Conference on Viral Vaccines and Gene Therapy (ICVVGT), International Conference on Viral Vaccines and Viral Gene Therapy Vectors (ICVVVGTV), International Conference on Gene Therapy Technologies (ICGTT), International Conference on Genetic Diagnosis and Gene Therapy (ICGDGT), International Conference on Veterinary Pharmaceutics and Gene Therapy (ICVPGT), International Conference on Veterinary Industrial Pharmacology and Gene Therapy (ICVIPGT), International Conference on Viral Vectors, Gene Therapy and Vaccines (ICVVGTV), International Conference on Immunotherapy, Immunogenetics and Vaccines (ICIIV), International Conference on Recent Advances in Gene Therapy Technologies (ICRAGTT), International Conference on Veterinary Pharmacology and Gene Therapy (ICVPGT), International Conference on Viral Vectors for Gene Therapy (ICVVGT), International Conference on Sports Medicine, Physiotherapy and Regenerative Therapies (ICSMPRT), International Conference on DNA Vaccines and Gene Therapy (ICDNAVGT), International Conference on General Physiotherapy (ICGP), Creative Commons Attribution 4.0 International license. Click here for more information about advertising. Will there ever be a place for two different modalities together, such as oncolytics and CAR-Ts? Get in touch and we will get back to you. In this roundtable, we provide an update on key questions, challenges and progress. Toll Free: +1-800-233-9014. All Events. This improved outlook comes amid the company's potential blockbuster drugs tracking ahead of schedule and targeted investments in Research . 2000-2023 All rights reserved. Recent Advances in Gene Therapy Technologies scheduled on June 10-11, 2025 in June 2025 in Barcelona is for the researchers, scientists, scholars, engineers, academic, scientific and university practitioners to present research activities that might want to attend events, meetings, seminars, congresses, workshops, summit, and symposiums. This site uses cookies to offer you a better user experience and to analyze site traffic. Founder / Advisor, InScienceWeTrust BioAdvisory / BioSpark Group, Samuel Zhang, PhD, MBA We would love for you to be one of them. Up Next: Advanced Therapies Week 2023, Miami, Florida. EVENT CALENDAR Up Next: Advanced Therapies Week 2023, Miami, Florida Advanced Therapies Week is the destination for developers, investors and solution providers whose goal is to bring cell and gene therapies to patients. Cell therapy combinations present many challenges due to risk and costs. Gene Therapy Conferences in USA 2022/2023/2024 is an indexed listing of upcoming meetings, seminars, congresses, workshops, programs, continuing CME courses, trainings, summits, and weekly, annual or monthly symposiums. American Society of Gene & Cell Therapy. Senior Director, Immuno-Oncology and Cellular Therapy Translational Research. $1,100 ! With the beginning of a new year and the resetting of conference budgets, what better time to secure your Ebube Orazulume en LinkedIn: 3rd Gene Therapy Comparability Summit 2023 This site uses cookies to offer you a better user experience and to analyze site traffic. VP, R&D, Director, Defence Therapeutics Inc, Laura Johnson, PhD On June 26, please join us at our Rare Disease Therapeutic Alliance 2023, which will feature 1on1 meetings with the select group of specialty pharma and biotech companies focused on developing therapies for some of the rare and orphan diseases. Investor Perspective on the State of the Current Market and Impact on the IO Cell Therapy Field CSO, Allogene Therapeutics. All cancellations must be sent by email at. There are a variety of ways you can support the 26thAnnual Meeting. EVP, R&D and Founding CSO, Capstan Therapeutics, David Peritt, PhD Youll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business. Oncology Drug Developer, Stealth Co, Mechanisms Driving CAR T Cells Activity and Failure. We will explore and discuss what worked, what didnt work and what could be done differently in future trials to enable and drive the more efficient and effective development of future cell therapies. Whether through world-class speakers, original content or industry-defining databases, this knowledge is delivered through a premium customer experience. London How do we get the t-cell redirecting field, it could be CART or bispecifics, working effectively with adaptive immune modulators? Go West in 2023! DQUAD 2023 is the industry lead summit, dedicated to bringing together pharma and biotech pioneers at the forefront of drug discovery, delivery and development, discussing the latest scientific breakthroughs, exploring innovative technologies and approaches to overcome drug discovery and development challenges, and future opportunities for novel therapeutic discovery. Our BPI 2022 agenda includes 8 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Take the opportunity to meet industry leaders and subject experts; and enhance your network globally through the networking events. Contact us to discover how our events can accelerate your drug development. Managing Director, Next Pillar Consulting, Ramy Ibrahim, MD Navigating through complexities of two different geographies for development and trials. Marcela Maus, MD, PhD And to understand how it works, well start at the basics. Cancellations received up and including September 18, 2022: full refund less a $80 towards the administrative fee. COO and President, Be Bio, Michael Klichinsky, PharmD, PhD Every event ensures the content you receive and the connections you access will truly give you the insight and . Gene Therapy conference listings are indexed in scientific databases like Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, EBSCO, BASE, WorldCAT, Sherpa/RoMEO, Compendex, Elsevier, Scopus, Thomson Reuters (Web of Science), RCSI Library, UGC Approved Journals, ACM, CAS, ACTA, CASSI, ISI, SCI, ESCI, SCIE, Springer, Wiley, Taylor Francis, and The Science Citation Index (SCI). Search by type of therapy, diagnosis, location of trial, and more. President & CSO, CUE Biopharma, Krishnan Viswanadhan, PharmD In addition, the summit covers emerging and related fields including Gene Editing & CRISPR, Cell Therapies, Gene Therapy for Cancer, Immunotherapy, Rare diseases, Blood Disorders, Neurological Disorders, Toxicology Studies, advances in manufacturing, regulatory and medical affairs, Commercialization Strategies, Business Models and Market Access. European Sales Contact Chief Commercial Officer, Immune Medicine, Adaptive Biotechnologies, Rachel Haurwitz, PhD ---. If you continue to use this site we will assume that you are happy with it. 20800 Swenson Dr. The Wayne County native and member of Calvary Baptist Church was a 1966 Jesup High School graduate and received two associate's degrees, one from South Georgia College in Douglas while playing baseball and then one at John A. Gupton School of Mortuary Science in Nashville . Clinical trial designs as contribution of components, single agent activity and/or developing multi-arm trials to address combinations. As the industry-leading rare gene therapy meeting, the. The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. The ISCT Annual Meeting is designed to connect cell and gene therapy translation professionals to educate, inspire, network, and collaborate. Here we learn about the process of developing a treatment. Register 52 Grosvenor Gardens, We speak to hundreds of biopharmaceutical experts from industry and academia every day. The Sweetheart Special is a USSSA Fast Pitch event in Jesup, GA and will be held from 02/11/2023 to 02/11/2023 Working towards robust and scalable manufacturing processes, this track will be dedicated to: As more gene therapy products progress through to pivotal trials and near approval, being prepared for launch and what lies ahead is now a nearing reality for many. As the industry-leading rare gene therapy meeting, the Gene Therapy for Rare Disorders is back at a landmark moment for the field. Advancing knowledge, awareness, + education of gene and cell therapies. 6th Gene Therapy for Rare Disorders 2023 | Partners. Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. To help progress your product into and through the clinic, our program will dive into: will take part in the 2023 hybrid conference! Gene Therapy Conferences 2023/2024/2025 will bring speakers from Asia, Africa, North America, South America, Antarctica, Europe, and Australia. The company aims to deliver a gene editing-based treatment . What would trials look like and how were going to get those done? From promise to reality: Delivering transformative therapies to patients. Email: Sales / General BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and . Wondering how to craft a great Annual Meeting abstract submission? SVP, Immuno-Oncology and Cellular Therapy, BMS, Michael Kalos, PhD February 7, 2023 Provide your contact information and your questions through the website and a distributor will reach out to you promptly. CBO, Gracell Biotechnologies, High-Throughput Approaches to Discover Novel Gene Functions in T-Cells. CSO, Century Therapeutics, Stefan Irion, MD Registration is free and allows users complete access to all sections of the site, including archived news items. This roundtable addresses: Leon Jun Tang, PhD As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. FDA Updates on Cell Therapy Browse our curated database of gene and cell therapy clinical trials from throughout the United States. New York Marriott at the Brooklyn Bridge, Brooklyn, NY. Registration is OPEN for the 26th Annual Meeting! Cancellations received from January 22, 2023: no refund will be made. 2000-2023 All rights reserved. They all bring tremendous potential, challenges and limitations. The North Carolina native had lived in Wayne County most of his life and was of the Baptist faith. About Us | Gene Therapy is a method of treatment by using DNA as a drug to treat disease by delivering therapeutic DNA into a patient's cells. The meeting would provide an opportunity to engage with thought leaders and researchers to discuss the latest breakthrough and the future of Cancer Immunotherapeutic Research. 10+ Sessions About Advancing Gene Therapy 2023 The 2023 Advancing Gene Therapy conference will be held in The Westin Walthum, MA. NOW OPEN: Register for the 26th Annual Meeting! ICGGT-203 Over the once many times, Gene remedy has come a regular talk for the scientists and experimenters from academia and assiduity each over the globe. 17 Jan 2023 January 17th - 20th 2023 I Miami Beach Convention Center LEARN MORE Advanced Therapies Awards 2023, Miami, Florida The four major areas of cell therapy moving forward include autologous, allogeneic, point of care and in vivo CAR-T. Visit our contact page for a quick response. The global society of cell and gene therapy annual meeting is the largest global yearly summit event for all those involved in the cell and gene therapy translation sector. This rapid-style session features updates from companies specializing in CAR-T modifications on progress, challenges and next steps. After a successful year of approvals and with even more decisions anticipated for 2023, improving clarity over regulatory expectations and maintaining an open dialogue between industry and regulatory bodies remains paramount. The International Journal of Molecular and Cellular Therapeutics. We share a common belief with the industry: that the potential of gene therapies is enormous. 50+ CELL, GENE & IMMUNOTHERAPY THOUGHT LEADERS INCLUDING: Christopher A. Bravery, Ph.D. Register Today! Pre-Filled Syringes and Injectable Drug Devices Europe, Cell & Gene Therapy Conferences at PepTalk 2023, Transdermal and Microneedle Drug Delivery, Next Generation Ophthalmic Drug Delivery Summit, 2nd Annual mRNA-Based Therapeutics Summit, 2nd Allogeneic Cell Therapies Summit Europe, 3rd TGF- for Immuno-Oncology Drug Development Summit, 6th Annual Cell & Gene Therapy Innovation Summit, Retinal Vascular Disease Drug Development Summit, 11th Alzheimers & Parkinsons (Gene Therapy) Drug Development Summit, 3rd Annual Gene Therapy for Muscular Disorders Summit, GENAP Summit 2023 - Gene & Cell Therapy Aseptic Processing Technology, 6th Antigen-Specific Immune Tolerance Summit, Cell & Gene Therapy Research & Development Congress Asia, 4th Supply Chain and Logistics for Cell Therapies Summit, 12th Spring Meeting of the International Society for BioProcess Technology, 6th Annual Gene Therapy for Rare Disorders 2023 Summit, Reuters Pharma USA 2023 - Cell and Gene Therapies, International Bioprocessing and Biologics 2023 - Cell and Gene Therapies, 2nd LNP Formulation & Process Development Summit 2023 - Gene Therapy delivery, mRNA Process Development & Manufacturing Summit Europe, The Economist's Cell & Gene Therapy summit, 4th Gene Therapy Analytical Development Europe Summit, ISBioTech Nucleic Acids meeting - Production of DNA and RNA Biotherapeutics, 2nd Next Generation RNA Therapeutics Summit, American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Global Biologics Cell and Gene Legal Summit, Annual meeting of the Netherlands Society of Gene & Cell Therapy, Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), Your conference not listed? News | Cell Therapy Manufacturing & New Business Models T: (+1) 617 455 4188 United States. Suite 300 President & CEO, TCR2 Therapeutics, Marc Lajoie, PhD What are the fundamental concerns and hesitations that VCs have in this space when they look at opportunities? Hanson Wade Assessing approaches to develop more targeted, less immunogenic novel capsids. January 11, 2023. VP Medical and Patient Affairs, Encoded Therapeutics, Inc. Senior Director of Technology, Gene Therapy, Repligen Corporation, Scientist II, Technical Development, Biogen, Director, Cell and Gene Therapy, Latham Biopharm Group, Chief, Division of Cellular and Molecular Therapy, University of Florida College of Medicine, FL, USA, Hamilton, Brook, Smith & Reynolds, MA, USA, Vice President Business Development and Alliances. The latest discoveries and most up-to-date research will be revealed and discussed at AGT-2023. VP & Head, Cell Therapy. 2 Day Conference + Workshop Day OR Discussion Day $3,197. Learn from your peers in academia, biotech, CDMOs, CROs, and regulatory organizations and what they are offering. European Orders: CEO & Scientific Founder, Anocca, Gavin MacBeath, PhD Gene therapies are redefining the treatment of a host of devastating diseases, giving hope to patients who previously had no therapeutic options. Senior Director, Immuno-Oncology and Cellular Therapy Translational Research, BMS, David Main, MBA Co-founder, VP, Head of Therapeutic Discovery, 3T Biosciences, Franois Gaudet, PhD This roundtable will address how to practically establish translational infrastructure that can generate actionable and informative data to support clinical trials. More US companies are shifting resources and doing early development work out of China to advance cancer treatments for patients. to begin at 12:20 pm, Roundtable #1: Addressing the Translational Research Paradigm And Generating the Right Information From your Translational Studies to Have Greater Impact. Submiting an Annual Meeting abstract is the best way to get your research in front of leaders and colleagues in the field. Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene. Director, Center for Biologics Evaluation and Research (CBER), FDA, GRAND OPENING OF THE IO Cell Therapy 360 and IO360 NETWORKING CAFE, Cell Therapy Manufacturing Progress Report and Novel Manufacturing Paradigms. Senior Director, Immuno-Oncology and Cellular Therapy Translational Research, BMS, Michael Kalos, PhD Associate Professor, Department of Microbiology and Immunology / Scientific Co-founder, Co-founder, VP, Head of Therapeutic Discovery, Chief Commercial Officer, Immune Medicine, Invivo, Point of Care, IPSCs, TILs, Modified TCRs, Synthetic Circuits, Vaccine Approaches, Neoantigen Targeting, Etc. Founder, Engenuity Life Sciences, Afternoon Break in the Exhibit Cafe & Partnering Meetings. Gene Forum takes the honour to invite you to the "15th International Genetics & Gene Therapy'' which will be held on July 26-27, 2023 Rome, Italy. VP, Cellular Therapy, Janssen Pharmaceuticals, Shivani Srivastava, MD By continuing to use this website, you accept our use of cookies. Director, Cellular Therapy Program and Associate Professor of Medicine, Harvard Medical School, Massachusetts General Hospital. #CIS2023 would bring together leading pharmaceutical and biotech companies, patient advocacy groups, government and regulatory authorities, and investors and solution providers. International Conference on Cell and Gene Therapy July 10-11, 2023 in Paris, France DIGITAL Conference Code: 23FRPA07ICCGT001 Submit Your Paper Author Registration Listener Registration About Venue Call For Papers Important Dates Committees Registration Fees Program Conference Photos Flyer The International Research Conference Aims and Objectives The four major areas of cell therapy moving forward include autologous, allogeneic, point of care and invivo CAR-T.